주입 펌프 시장 : 제품, 모드, 조작, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Infusion Pumps Market was valued at USD 18.03 billion in 2023, expected to reach USD 19.25 billion in 2024, and is projected to grow at a CAGR of 7.21%, to USD 29.36 billion by 2030.

Infusion pumps are crucial medical devices used for administering medications, nutrients, and fluids to patients in precise dosages. Their scope is broad, encompassing various types like syringe, elastomeric, and peristaltic pumps, each designed for specific applications such as chemotherapy, insulin delivery, and pain management. The necessity of infusion pumps is underscored by their ability to automate and control dosage rates, enhancing accuracy and patient safety compared to manual administration. Applications extend across numerous healthcare settings, including hospitals, home care, ambulatory care, and in specialty areas like cancer treatment and diabetes management. The end-use scope predominantly involves healthcare providers, homecare patients, and pharmaceutical companies.

Market insights reveal robust growth prospects driven by technological advancements, rising prevalence of chronic diseases, and increasing demand for home healthcare devices. Factors such as the aging population, growing healthcare infrastructure in emerging markets, and the integration of smart technologies like IoT and AI are key growth influencers. Opportunities lie in innovative product development, such as wearable and wireless infusion pumps, and expanding application areas, particularly in personalized medicine. Recommendations to capitalize on these opportunities include intensifying R&D efforts, forging strategic alliances for technology integration, and expanding market penetration in untapped regions.

However, challenges exist, such as stringent regulatory requirements, risks of medication errors, and high device costs which can hinder market growth. The complexity in handling and maintenance also poses limitations, requiring better training and user-friendly designs. The best areas for innovation and research involve enhancing device interoperability, improving real-time monitoring capabilities, and building robust cybersecurity measures to protect patient data. Companies should focus on solutions that enhance both functionality and patient comfort. The market's nature is characterized by rapid technological advancements and a strong competitive landscape, pushing players to continuously innovate and adapt to meet evolving healthcare needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infusion Pumps Market

The Infusion Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing surgical procedures and need for infusion pumps for continuous medication delivery
  • Rising demand for ambulatory infusion pumps in homecare settings
• Market Restraints
  • Noticeable incidences of product recall due to medical error
• Market Opportunities
  • Advancements in infusion pumps with AI, ML & IoT technologies
  • Improving reimbursement availability for infusion pumps
• Market Challenges
  • Technical complexities and operational limitations of infusion pumps

Porter's Five Forces: A Strategic Tool for Navigating the Infusion Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infusion Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infusion Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infusion Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infusion Pumps Market

A detailed market share analysis in the Infusion Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infusion Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infusion Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include Micrel Medical Devices SA, Intera Oncology, Inc., Siemens AG, SOOIL Developments Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Terumo Corporation, FUJIFILM Corporation, Shenzhen MedRena Biotech Co., Ltd., Merck KGaA, Becton, Dickinson and Company, Insulet Corporation, Medline Industries, LP, ICU Medical, Inc., B. Braun SE, Tandem Diabetes Care, Inc., New Era Pump Systems Inc., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Intuvie Holdings LLC, Avanos Medical, Inc., Teleflex Incorporated, Moog Inc., Abbott Laboratories, Baxter International Inc., Fresenius Se & Co. KGaA, Ivenix, Inc., Boston Scientific Corporation, Ypsomed AG, Canadian Hospital Specialties Limited, Chemyx Inc., Bio-x, 3M Company, JMS Co., Ltd., Medtronic PLC, Epic Medical Pty Ltd., Thermo Fisher Scientific Inc., Nipro Corporation, Narang Medical Limited, GE HealthCare Technologies Inc., and Bayer AG.

Market Segmentation & Coverage

This research report categorizes the Infusion Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump, Insulin Pump, PCA Pump, Syringe Pump, and Volumetric Pump.
• Based on Mode, market is studied across Portable Infusion Pump and Stationary Infusion Pump.
• Based on Operation, market is studied across Electrically Operated and Mechanically Operated.
• Based on Application, market is studied across Chemotherapy, Diabetes, Gastroenterology, Hematology, Pain Management, and Pediatrics.
• Based on End User, market is studied across Academic & Research Institute, Ambulatory Care Setting, Home Care Setting, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing surgical procedures and need for infusion pumps for continuous medication delivery
    • 5.1.1.2. Rising demand for ambulatory infusion pumps in homecare settings
  • 5.1.2. Restraints
    • 5.1.2.1. Noticeable incidences of product recall due to medical error
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in infusion pumps with AI, ML & IoT technologies
    • 5.1.3.2. Improving reimbursement availability for infusion pumps
  • 5.1.4. Challenges
    • 5.1.4.1. Technical complexities and operational limitations of infusion pumps
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Advancements to improve the performance of insulin pumps to improve disease outcomes for diabetic patients
  • 5.2.2. Mode: Growing patient preference for portable infusion pumps due to innovations in homecare
  • 5.2.3. Operation: Electrically operated infusion pumps offer greater control and monitoring capabilities
  • 5.2.4. Application: Need for infusion pumps with continuous glucose level monitoring and precise dose administration for diabetes patients
  • 5.2.5. End-User: Adoption of highly-reliable and safe infusion pumps that cater to multiple disease cases in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Infusion Pumps Market, by Product

• 6.1. Introduction
• 6.2. Ambulatory Infusion Pump
• 6.3. Enteral Infusion Pump
• 6.4. Implantable Infusion Pump
• 6.5. Insulin Pump
• 6.6. PCA Pump
• 6.7. Syringe Pump
• 6.8. Volumetric Pump

7. Infusion Pumps Market, by Mode

• 7.1. Introduction
• 7.2. Portable Infusion Pump
• 7.3. Stationary Infusion Pump

8. Infusion Pumps Market, by Operation

• 8.1. Introduction
• 8.2. Electrically Operated
• 8.3. Mechanically Operated

9. Infusion Pumps Market, by Application

• 9.1. Introduction
• 9.2. Chemotherapy
• 9.3. Diabetes
• 9.4. Gastroenterology
• 9.5. Hematology
• 9.6. Pain Management
• 9.7. Pediatrics

10. Infusion Pumps Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institute
• 10.3. Ambulatory Care Setting
• 10.4. Home Care Setting
• 10.5. Hospital

11. Americas Infusion Pumps Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Infusion Pumps Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Infusion Pumps Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
  • 14.3.2. Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
  • 14.3.3. Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
  • 14.3.4. FDA Clears New Infusion Pump And Software From ICU Medical
  • 14.3.5. B. Braun Launches DoseTrac Enterprise Infusion Management Software
  • 14.3.6. Medtronic Agrees To Buy Korean Insulin Patch Pump Maker For USD 738 Million To Boost Diabetes Business
  • 14.3.7. Eitan Medical Launches Connected Avoset Infusion Platform
  • 14.3.8. FDA Approves Medtronic MiniMed 780G System World's First Insulin Pump with Meal Detection Technology Featuring 5-Minute Auto Corrections
  • 14.3.9. MLH Enhances Medication Safety with Epic-Integrated IV Pumps
  • 14.3.10. Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
  • 14.3.11. Mindray Launches BeneFusion i/u Series Infusion Systems, Providing Visible Safety for All with Ease
  • 14.3.12. Tandem Diabetes Care Completes Acquisition of Insulin Pump Maker AMF Medical

Companies Mentioned

• 1. Micrel Medical Devices SA
• 2. Intera Oncology, Inc.
• 3. Siemens AG
• 4. SOOIL Developments Co., Ltd.
• 5. Longer Precision Pump Co. Ltd. by Halma PLC
• 6. Terumo Corporation
• 7. FUJIFILM Corporation
• 8. Shenzhen MedRena Biotech Co., Ltd.
• 9. Merck KGaA
• 10. Becton, Dickinson and Company
• 11. Insulet Corporation
• 12. Medline Industries, LP
• 13. ICU Medical, Inc.
• 14. B. Braun SE
• 15. Tandem Diabetes Care, Inc.
• 16. New Era Pump Systems Inc.
• 17. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
• 18. Intuvie Holdings LLC
• 19. Avanos Medical, Inc.
• 20. Teleflex Incorporated
• 21. Moog Inc.
• 22. Abbott Laboratories
• 23. Baxter International Inc.
• 24. Fresenius Se & Co. KGaA
• 25. Ivenix, Inc.
• 26. Boston Scientific Corporation
• 27. Ypsomed AG
• 28. Canadian Hospital Specialties Limited
• 29. Chemyx Inc.
• 30. Bio-x
• 31. 3M Company
• 32. JMS Co., Ltd.
• 33. Medtronic PLC
• 34. Epic Medical Pty Ltd.
• 35. Thermo Fisher Scientific Inc.
• 36. Nipro Corporation
• 37. Narang Medical Limited
• 38. GE HealthCare Technologies Inc.
• 39. Bayer AG